Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Jul;38(7):2688-95.
doi: 10.1128/JCM.38.7.2688-2695.2000.

Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya

Affiliations
Comparative Study

Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya

S Emery et al. J Clin Microbiol. 2000 Jul.

Abstract

Accurate and sensitive quantification of human immunodeficiency virus type 1 (HIV-1) RNA has been invaluable as a marker for disease prognosis and for clinical monitoring of HIV-1 disease. The first generation of commercially available HIV-1 RNA tests were optimized to detect the predominant HIV-1 subtype found in North America and Europe, subtype B. However, these tests are frequently suboptimal in detecting HIV-1 genetic forms or subtypes found in other parts of the world. The goal of the present study was to evaluate the performance of a new viral load assay with non-subtype B viruses. A transcription-mediated amplification method for detection and quantitation of diverse HIV-1 subtypes, called the Gen-Probe HIV-1 viral load assay, is under development. In this study we examined the performance of the Gen-Probe HIV-1 viral load assay relative to that of the commonly used commercial HIV-1 RNA assays using a panel of primary isolates from Kenya. For comparison, we included several subtype B cloned viruses, and we quantified each virus using an in-house quantitative-competitive reverse transcriptase PCR (QC-RT-PCR) method and gag(p24) antigen capture. The Gen-Probe HIV-1 viral load assay and a version of the Roche AMPLICOR HIV-1 MONITOR test (version 1.5) that was designed to detect a broader range of subtypes were both sensitive for the quantification of Kenyan primary isolates, which represented subtype A, C, and D viruses. The Gen-Probe HIV-1 viral load assay was more sensitive for the majority of viruses than the Roche AMPLICOR HIV-1 MONITOR test version 1.0, the Bayer Quantiplex HIV RNA 3.0 assay, or a QC-RT-PCR method in use in our laboratory, suggesting that it provides a useful method for quantifying HIV-1 RNAs from diverse parts of the world, including Africa.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Comparison of log10 RNA plasma viral load results from Gen-Probe assay versus other assays by HIV-1 clade. ◊, clade A; ✠, clade B; +, clade C; ▿, clade D; ○, unknown clade.
FIG. 2
FIG. 2
p24 antigen levels versus log10 RNA plasma viral load by HIV-1 clade. ◊, clade A; ✠, clade B; +, clade C; ▿, clade D; ○, unknown clade.
FIG. 3
FIG. 3
Reproducibility of Gen-Probe assay by operator, dilution, and clade. Cl, confidence limit; undil, undiluted.

Similar articles

Cited by

References

    1. Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 1997;11:859–865. - PubMed
    1. Berger A, Braner J, Doerr H W, Weber B. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology. 1998;41:24–34. - PubMed
    1. Bodrug S, Domingo R, Holloway J, Sanders M, Nunomura K, Sloan C, Billyard B. Gen-Probe single tube quantitative HIV assay. J Clin Microbiol Infect. 1997;3:1050.
    1. Brodine S K, Mascola J R, Weiss P J, Ito S I, Porter K R, Artenstein A W, Garland F C, McCutchan F E, Burke D S. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet. 1995;346:1198–1199. - PubMed
    1. Brodine S K, Shaffer R A, Starkey M J, Tasker S A, Gilcrest J L, Louder M K, Barile A, VanCott T C, Vahey M T, McCutchan F E, Birx D L, Richman D D, Mascola J R. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med. 1999;131:502–506. - PubMed

Publication types